Filing Details
- Accession Number:
- 0001225208-16-033171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-11 18:03:48
- Reporting Period:
- 2016-05-09
- Filing Date:
- 2016-05-11
- Accepted Time:
- 2016-05-11 18:03:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1372915 | C Ian Read | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-05-09 | 250,000 | $25.87 | 1,446,738 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-05-09 | 25,000 | $24.43 | 1,471,738 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-05-09 | 3,908 | $33.81 | 1,467,830 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-09 | 271,092 | $33.80 | 1,196,738 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-09 | 250,000 | $0.00 | 250,000 | $25.87 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-09 | 25,000 | $0.00 | 25,000 | $24.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-02-22 | 2017-02-21 | No | 4 | M | Direct |
| 0 | 2010-09-28 | 2017-09-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,297 | Indirect | By Rule 16b-3 Plan |
| Common Stock | 480,000 | Indirect | By Trust |
Footnotes
- In accordance with the provisions of the reporting person's Grantor Retained Annuity Trust (GRAT): 33,809 shares were transferred from the GRAT to the reporting person's direct ownership on September 17, 2015; 150,000 shares were transferred from reporting person's direct ownership to the GRAT on December 2, 2015 and 330,000 shares were transferred from reporting person's direct ownership to the GRAT on March 18, 2016.
Billionaire Hedge Funds
